Transcat, Inc. TRNS

87.73 1.60 1.86% as of 25 Sep
Market cap
$806.2M
P/E
237×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.10
Total sells 0.05
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — 1 —
Sell — — — — — — — — — — 1 —
Insider Ownership 2.38%

Capital & Financial Ratios

Market Cap 806.16
Revenue 348.40
Net Income 3.45
Free Cash Flow 25.36
Net Debt 103.68
Current Ratio 2.49
Debt/Equity 0.36
P/E ratio 237.11
P/S ratio 2.36
P/B ratio 2.71
Past 5Y EPS Growth 7.80%
This Y EPS Growth 2.99%
Next Y EPS Growth 14.38%
Next 5Y EPS Growth 11.93%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2018 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2024 2025 2026 Q'26
Cash 35 2 5 7
Receivables 48 56 66 67
Inventory 17 14 14 15
Other — — — —
105 78 92 96
2024 2025 2026 Q'26
Payables 11 17 18 20
ST’ Debt 2 2 — —
Other — — — —
33 34 40 38
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 10.51% 13.87% 12.91%
Cash Flow 12.24% 8.07% 27.16%
Earnings 2.69% (7.15%) (20.47%)
Book Value 22.69% 31.98% 44.50%

Revenue

Jun Sep Dec Mar Year
’26 93 — — — —
’26 76 82 84 89 332
’25 67 68 67 77 278
’24 61 63 65 71 259
’23 55 56 57 62 231
’22 48 50 51 56 205
’21 39 42 44 49 173
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Jun Sep Dec Mar Year
’26 9 — — — —
’26 4 13 12 6 35
’25 9 7 13 11 39
’24 8 8 11 6 33
’23 2 3 9 3 17
’22 2 5 5 5 18
’21 4 8 3 8 24
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Jun Sep Dec Mar Year
’26 5 — — — —
’26 (1) 8 9 3 20
’25 5 3 11 8 27
’24 5 6 7 2 19
’23 0 1 6 1 8
’22 1 3 3 1 8
’21 3 7 2 6 17
in millions of $ · fiscal quarters ending in the months shown

EPS

Jun Sep Dec Mar Year
’26 0.14 — — — —
’26 0.35 0.14 (0.12) 0.21 0.57
’25 0.48 0.35 0.25 0.48 1.57
’24 0.38 0.06 0.38 0.77 1.63
’23 0.40 0.31 0.21 0.48 1.40
’22 0.49 0.40 0.21 0.40 1.50
’21 0.11 0.27 0.23 0.42 1.03
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
10.49 13.05 18.73 16.50 32.54 50.32 71.04 94.29 50.23 56.00

Analyst estimates 2027–2029

Powerpack
Low Price
15.15 25.35 34.18 36.49 101.05 95.79 115.41 147.12 111.29 100.00
High Price
585 606 685 772 765 918 1,030 1,104 1,245 1,413
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
144 155 161 173 173 205 231 259 278 332
Revenue
24.30% 24.13% 24.45% 24.54% 26.61% 28.51% 29.65% 32.30% 32.13% 32.63%
Gross Margin
7 8 9 10 10 13 13 18 18 8
EBT
4.98% 5.12% 5.74% 5.62% 5.76% 6.44% 5.85% 7.11% 6.58% 2.41%
EBT Margin
5 6 7 8 8 11 11 14 15 5
Net Income
6 6 6 7 8 10 11 14 19 26
Depreciation
20.57 21.78 22.36 23.61 23.35 27.34 30.53 31.49 30.31 35.56
Revenue/Sh
0.65 0.83 0.99 1.10 1.05 1.52 1.42 1.66 1.58 0.58
Earnings/Sh
1.08 1.39 1.75 1.58 3.18 2.35 2.24 3.96 4.24 3.73
Cash Flow/Sh
(0.74) (0.82) (0.97) (0.87) (0.89) (1.34) (1.25) (1.61) (1.32) (1.64)
Capex/Sh
0.34 0.56 0.77 0.70 2.30 1.01 1.00 2.35 2.93 2.09
Free CF/Sh
6.21 7.21 8.29 9.15 10.11 11.50 13.19 27.33 31.23 32.21
Book Value/Sh
7 7 7 7 7 7 8 8 9 9
Shares
20.16 18.61 22.85 24.09 46.74 53.38 63.40 68.27 46.82 126.64
PE Ratio
0.62 0.71 1.02 1.12 2.10 2.97 2.93 3.51 2.46 2.07
PS Ratio
2.05 2.14 2.76 2.90 4.85 7.06 6.77 4.05 2.38 2.28
PB Ratio
0.80 0.85 1.15 1.29 2.21 3.20 3.13 3.39 2.57 2.36
EV/Sales
49.00 33.06 33.19 43.38 22.50 86.51 95.74 45.52 26.59 39.98
EV/FCF
8 10 13 12 24 18 17 33 39 35
Op' Cash Flow
(5) (6) (7) (6) (7) (10) (9) (13) (12) (15)
Capex
2 4 6 5 17 8 8 19 27 20
FCF
16 19 23 28 24 32 39 72 44 53
Working Cap'
27 23 21 30 20 48 49 4 33 100
Total Debt
26 22 20 30 19 47 48 (31) 31 95
Net Debt
43 51 60 67 75 86 100 225 287 301
Sh' Equity
5.36% 6.27% 7.07% 6.91% 5.99% 7.34% 5.72% 5.65% 4.31% 1.24%
ROA
7.10% 7.66% 8.01% 7.00% 7.36% 6.63% 6.90% 6.37% 3.51% 2.10%
ROIC
10.99% 12.50% 12.88% 12.73% 10.96% 14.11% 11.50% 8.40% 5.67% 1.83%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Mar 2026 · latest quarter Jun 2026

Transcat, Inc. peers in Specialty Business Services

All 44 Specialty Business Services stocks →

Transcat, Inc. (TRNS) key facts

  • Transcat, Inc. (TRNS) is a Specialty Business Services company in the Industrials sector, listed on Nasdaq.
  • Transcat, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $331.9 million, up 19.2% from fiscal 2025.
  • Net income was $5.4 million, or $0.58 per share (basic), a net margin of 1.62%.
  • As of September 25, 2026, TRNS traded at $87.73, a market capitalization of $806.2 million.
  • At that price the stock trades at 237× trailing-twelve-month earnings and 2.4× sales.
  • Return on equity was 1.83% and debt-to-equity 0.36.

Source: company filings (standardised) and stockrow calculations.

Transcat, Inc. (TRNS) Latest News

News by impact score

Fine-tune

22 Sep

3

Transcat, Inc. (TRNS) gained about 21.9% over the past six months, trading near $88.69 and outperforming the S&P 500 by roughly 5.7% on the strength of solid quarterly results. Despite the rally, the piece argues TRNS isn’t a buy: EPS has grown a tepid 4.1% CAGR over five years while revenue expanded about 13.8%, ROIC average around 6.9% and recently declining, signaling limited profitable growth opportunities. At roughly 43.8x forward earnings, the valuation is rich and the stock is portrayed as a market darling with much good news priced in. The analysis suggests an alternative stock to buy instead and mentions an AI-driven stock-picking system that has surfaced names like Nvidia and Palantir in the past. Weak earnings quality and declining ROIC paired with a rich forward valuation create a moderate sentiment shift rather than a fundamental overhaul.

31 Aug

4

Transcat acquires Southeastern Biomedical to expand its biomedical calibration channel. Acquisition represents major strategic move to strengthen calibration operations and market position.

13 Aug

3

Transcat Inc. addressed five key analyst questions during its Q2 earnings call, covering revenue trends, acquisition integration, calibration services demand, margin pressures, and growth initiatives in distribution and service segments. Earnings call details offer targeted operational insights that may shift short-term investor sentiment without altering long-term company trajectory.

11 Aug

4 transcript

Transcat (TRNS) held its Q1 2027 earnings call, covering financial results, operational updates, and outlook. Earnings call details directly shape investor views on revenue, margins, and guidance.

5 Aug

3

Transcat, Inc. held its Q1 2027 earnings call covering financial results, operational updates, and forward guidance for the calibration and testing services provider. Q1 earnings figures and guidance offer moderate insight into near-term financial performance and investor sentiment.

3

Transcat Inc reported strong service growth and strategic progress in its Q1 2027 earnings call. Strong service growth signals improved operational results that can support revenue gains but remains within normal quarterly updates.

4 Aug

4

Transcat reported strong fiscal first quarter 2027 results with double-digit service organic revenue growth and service gross margin expansion. Strong quarterly revenue growth and margin gains signal improved operational performance that can materially lift investor sentiment and valuation.

3 transcript

Transcat reported Q1 results in its earnings call, covering revenue, earnings per share, segment performance, and forward guidance. Q1 earnings data and guidance provide moderate insight into near-term financial trajectory and investor positioning.

3

Transcat, Inc. posted Q1 earnings and revenues above analyst estimates. Beating quarterly estimates typically lifts near-term stock sentiment without shifting long-term trajectory.

3

Transcat, Inc. posted strong sales results for Q2 CY2026. Strong quarterly sales provide a moderate positive signal for near-term financial performance and investor sentiment.

4 Jun

3

Transcat is positioned as the surging industrials stock to own for decades while two sector peers are flagged as risky. Analyst endorsement of Transcat as long-term holding can lift investor sentiment and near-term trading interest.

27 May

4

Transcat Inc reported strong Q4 2026 revenue growth and outlined strategic expansion plans. Strong revenue growth and strategic expansion signal major positive shifts in financial performance and market positioning.

3 transcript

Transcat, Inc. held its Q4 2026 earnings call covering financial results, operational updates, and forward guidance. Earnings call delivers updated financials and outlook that moderately shape near-term investor views and valuation.

26 May

4

Transcat, Inc. reported strong fiscal fourth quarter 2026 financial results with continued high single-digit service organic revenue growth. Strong quarterly earnings and sustained revenue growth directly improve investor sentiment and near-term stock performance.

3 transcript

Transcat reported Q4 results including revenue, earnings and operational metrics during its earnings call. Quarterly earnings updates supply financial details that moderately shape near-term investor expectations.

3 transcript

Transcat, Inc. (TRNS) released Q4 2026 earnings transcript covering financial results and executive discussion. Earnings call details financial performance and outlook that can shift near-term investor views.

3

Transcat (TRNS) Q4 earnings results are compared against analyst estimates with analysis of key operating and financial metrics. Quarterly earnings versus estimates directly affect near-term investor views of Transcat financial performance.

3

Transcat missed Q1 CY2026 sales expectations. Quarterly sales miss signals weaker revenue performance and may pressure near-term stock valuation.

25 May

3 transcript

Transcat reported Q2 2026 results and outlook during its earnings call. Earnings figures and guidance update financial trajectory and investor positioning.

3 transcript

Transcat, Inc. held its Q3 2026 earnings call, covering quarterly financial results, operations and outlook. Quarterly earnings data and guidance can move near-term stock sentiment and valuation.

24 May

3

Transcat, Inc. (TRNS) is scheduled to report earnings tomorrow. Earnings release may move stock price and near-term sentiment.

8 May

3

Transcat (TRNS) gained from robust underlying demand and heightened customer activity. Robust demand and customer activity moderately boost financial performance and market sentiment.

9 Apr

4

Transcat, Inc. (TRNS) acquires SCM Metrology and Laboratories S.A. to expand into Latin America. Acquisition provides geographic expansion into Latin America, enhancing revenue potential and market reach.

9 Mar

4

Transcat, Inc. (TRNS) appoints Jaime Irick as President and Chief Executive Officer. CEO appointment signals major leadership change with potential to reshape strategy and influence market performance.

11 Feb

3

Transcat, Inc. (TRNS) is highlighted among three stocks that Wall Street analysts favor, but caution is advised due to potential market volatility and economic uncertainties. Analysts express concerns about the company's valuation and the broader market environment, suggesting that while TRNS has strong fundamentals, investors should remain vigilant. The article emphasizes the importance of careful consideration before investing in TRNS amidst fluctuating market conditions. Concerns about market volatility and valuation may moderately influence investor sentiment and performance.

10 Feb

4 transcript

Transcat, Inc. held its Q4 earnings call, addressing key analyst questions regarding financial performance, market strategies, and future growth initiatives. The company highlighted its commitment to innovation and customer service, while also discussing challenges faced in the current market environment. Analysts sought clarity on revenue projections and operational efficiencies, with management providing insights into upcoming product launches and strategic partnerships aimed at enhancing competitive positioning. Significant strategic moves and product launches discussed could alter the company's trajectory and investor sentiment.

5 Feb

4

Transcat, Inc. (TRNS) is highlighted for its strong focus on recurring revenue, which is expected to enhance its financial stability and growth potential. The company has been successful in expanding its service offerings and customer base, positioning itself favorably in the market. Analysts note that this emphasis on recurring revenue streams could lead to improved profitability and investor confidence, making TRNS an attractive investment opportunity. The company's strategic focus on recurring revenue is likely to significantly impact its future performance and market positioning.

4 Feb

4 transcript

Transcat, Inc. (TRNS) reported robust revenue growth in Q3 2026, driven by strategic initiatives and increased demand for its products and services. The company highlighted strong performance across its segments, with notable gains in both sales and profitability. Management expressed optimism about future growth prospects, emphasizing ongoing investments in technology and market expansion. Overall, the earnings call reflected a positive outlook for Transcat amid a competitive landscape. Significant revenue growth and strategic initiatives are likely to alter the company's trajectory and enhance investor sentiment.

3

Transcat, Inc. (TRNS) reported growth driven by its rental channel and regulated markets, despite facing margin pressure. The company highlighted strong performance in these sectors, which contributed positively to its overall financial results. However, challenges related to margins were noted, indicating potential areas of concern moving forward. Growth in rental and regulated markets may positively influence financial performance, but margin pressures could limit overall impact.

3 Feb

4 transcript

Transcat, Inc. reported its Q3 earnings, highlighting strong revenue growth driven by increased demand in its calibration services and distribution segments. The company noted improvements in operational efficiency and strategic investments aimed at expanding its market presence. Management expressed optimism about future performance, citing ongoing projects and a robust pipeline of opportunities. Overall, the earnings call reflected a positive outlook for the company amidst a competitive landscape. Strong revenue growth and strategic investments indicate significant potential for future performance.

stockrow.com/TRNS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com